Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Keunyoung | - |
dc.contributor.author | Kim, Jung-Jun | - |
dc.contributor.author | Jung, Yeryeon | - |
dc.contributor.author | Noh, Ji-Yoon | - |
dc.contributor.author | Syed, Ahmed Shah | - |
dc.contributor.author | Kim, Chul Young | - |
dc.contributor.author | Lee, Moo-Yeol | - |
dc.contributor.author | Lim, Kyung-Min | - |
dc.contributor.author | Bae, Ok-Nam | - |
dc.contributor.author | Chung, Jin-Ho | - |
dc.date.accessioned | 2021-06-22T14:43:06Z | - |
dc.date.available | 2021-06-22T14:43:06Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2017-01 | - |
dc.identifier.issn | 0163-3864 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/10585 | - |
dc.description.abstract | Despite the increasing attention on the therapeutic potential of Curcuma longa (turmeric), the biological activities of curcuminoids other than curcumin are not well understood. Here, we investigated antivasoconstrictive activities of C. longa extract and its ingredients using freshly isolated rat aortic rings. C. longa extract significantly suppressed agonist-stimulated vasoconstriction, and cyclocurcumin was found to be the most potent (IC50 against phenylephrine-induced vasoconstriction: 14.9 +/- 1.0 mu M) among the 10 tested ingredients including four curcuminoids. Cyclocurcumin significantly inhibited contraction of vascular smooth muscle, which was mediated by the suppression of myosin-light-chain phosphorylation and calcium influx via the L-type calcium channel. The inhibitory effect of cyclocurcumin was observed to be reversible and without cytotoxicity. Taken together, we demonstrated that cyclocurcumin, a bioactive ingredient in C. longa, may have a therapeutic potential as a novel antivasoconstrictive natural product. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.title | Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Chul Young | - |
dc.contributor.affiliatedAuthor | Bae, Ok-Nam | - |
dc.identifier.doi | 10.1021/acs.jnatprod.6b00331 | - |
dc.identifier.scopusid | 2-s2.0-85010903316 | - |
dc.identifier.wosid | 000393089600026 | - |
dc.identifier.bibliographicCitation | JOURNAL OF NATURAL PRODUCTS, v.80, no.1, pp.196 - 200 | - |
dc.relation.isPartOf | JOURNAL OF NATURAL PRODUCTS | - |
dc.citation.title | JOURNAL OF NATURAL PRODUCTS | - |
dc.citation.volume | 80 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 196 | - |
dc.citation.endPage | 200 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Plant Sciences | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Plant Sciences | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | HIGH-FAT DIET | - |
dc.subject.keywordPlus | CURCUMINOIDS | - |
dc.subject.keywordPlus | RATS | - |
dc.subject.keywordPlus | TONE | - |
dc.subject.keywordAuthor | HIGH-FAT DIET | - |
dc.subject.keywordAuthor | CURCUMINOIDS | - |
dc.subject.keywordAuthor | RATS | - |
dc.subject.keywordAuthor | TONE | - |
dc.identifier.url | https://pubs.acs.org/doi/10.1021/acs.jnatprod.6b00331 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.